1. P045 Switching from boosted atazanavir (ATV) plus FTC/TDF to a TAF-based single tablet regimen (STR): week 48 data in virologically suppressed adults. (30th June 2016) Authors: Orkin, Chloe; Rjinders, Bart; Stephan, Christoph; McKellar, Mehri; Kiertiburanakul, Sasisopin; Arribas, Jose; Murphy, Daniel; Bloch, Mark; Liu, YaPei; Fordyce, Marshall; Yau, Stuart; McCallister, Scott Journal: Sexually transmitted infections Issue: Volume 92(2016)Supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P099 Renal Safety of Tenofovir Alafenamide in Patients at High Risk of Kidney Disease. (30th June 2016) Authors: Waters, Laura; Wohl, David; Thalme, Anders; Finlayson, Robert; Oka, Shinichi; Das, Moupali; Yau, Stuart; Fordyce, Marshall Journal: Sexually transmitted infections Issue: Volume 92(2016)Supplement 1 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗